Nano-enabled medical applications / (Record no. 17550)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05369cam a2200577Ki 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9780429399039 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | FlBoTFG |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220724194431.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200913s2021 si o 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | OCoLC-P |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429677901 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429677892 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429677898 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429677885 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 042967788X |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429399039 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429399030 |
| Qualifying information | electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429677908 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9789814800327 |
| Qualifying information | hardcover |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9814800325 |
| Qualifying information | hardcover |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1194960602 |
| Canceled/invalid control number | (OCoLC)1195441736 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC-P)1194960602 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | R857.N34 |
| Item number | N36 2021eb |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 009000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | SCI |
| Subject category code subdivision | 010000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TBN |
| Source | bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 610.28 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Nano-enabled medical applications / |
| Statement of responsibility, etc. | edited by Lajos P. Balogh. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Singapore : |
| Name of producer, publisher, distributor, manufacturer | Jenny Stanford Publishing Pte. Ltd., |
| Date of production, publication, distribution, manufacture, or copyright notice | [2021] |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Nanomedicine's most cited ; |
| Volume/sequential designation | volume 2 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Cover -- Half Title -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- 1 Intelligent Nanomaterials for Medicine: Carrier Platforms and Targeting Strategies-State of the Art -- 1.1 Introduction -- 1.2 Nanotechnology Carrier Platforms Suited for Switch Functionality -- 1.2.1 Micelles and Liposomes -- 1.2.2 Polymeric Systems -- 1.2.3 Dendrimers -- 1.2.4 Carbon Nanotubes -- 1.2.5 Metallic Nanoparticles -- 1.2.6 Other Organic Nanoparticles: Carbohydrate-Based NPs, e.g., Chitosan and Starch -- 1.2.7 Quantum Dots and Carbon Quantum Dots -- 1.2.8 Nanogels |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1.2.9 Peptide-Based Nanoparticles as Delivery System -- 1.3 Advanced Functionality Including Internal and External Stimuli-Responsiveness -- 1.4 Engineering Cell and Tissue Interaction at the Nanoscale -- 1.4.1 Targeting Strategies -- 1.4.1.1 Passive targeting -- 1.4.1.2 Active targeting -- 1.4.2 Endocytotic Cellular Uptake -- 1.4.3 Cellular Uptake by Cell-Penetrating Peptides -- 1.4.4 Endosomal Escape -- 1.4.5 Exocytosis -- 1.5 Clinical Application of Nanomaterials -- 1.5.1 The Clinical Trial Landscape: An Emphasis on Cancer |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1.5.2 Potential Risk Factors Regarding Approved Nanoparticle-Based Therapies -- 1.6 Conclusions and Outlook -- 2 Nanocarriers as an Emerging Platform for Cancer Therapy -- 2.1 Passive and Active Targeting -- 2.2 Types of Targeting Agents -- 2.3 The Arsenal of Nanocarriers -- 2.4 The Challenges of Multidrug Resistance -- 2.5 Into the Future -- 3 Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles -- 3.1 Well-Controlled Synthesis of Nanoparticles -- 3.2 Evaluation and Screening of Nanoparticles -- 3.3 Future Prospects -- 4 Theranostic Nanomedicine |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.1 Introduction -- 4.2 Imaging Drug Delivery -- 4.3 Imaging Drug Release -- 4.4 Imaging Drug Efficacy -- 4.5 Conclusions -- 5 The Emerging Field of RNA Nanotechnology -- 5.1 Significance and Uniqueness of RNA Nanotechnology -- 5.2 Distinct Attributes of RNA inside the Body -- 5.3 Techniques for Constructing RNA Nanoparticles -- 5.4 Applications of RNA Nanotechnology -- 5.5 Challenges and Perspectives -- 6 Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress -- 6.1 Introduction -- 6.2 Principles of Drug Targeting to Tumors -- 6.2.1 Passive Targeting |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 6.2.2 Active Targeting to Cancer Cells -- 6.2.3 Active Targeting to Endothelial Cells -- 6.2.4 Triggered Drug Delivery -- 6.3 Pitfalls in Drug Targeting to Tumors -- 6.3.1 Extravasation and the EPR Effect -- 6.3.2 Penetration -- 6.3.3 Active Targeting -- 6.3.4 Formulation -- 6.3.5 Efficacy vs. Toxicity -- 6.3.6 Metastasis -- 6.3.7 Personalization -- 6.3.8 Translation -- 6.4 (Pre-) Clinical Progress -- 6.5 Conclusion -- 7 Biomolecular Coronas Provide the Biological Identity of Nanosized Materials -- 7.1 Nanoscale Engagement with Biological Processes |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book is the second in a series presenting articles that received the most citations in recent years in nanomedicine. The series is edited by, a prominent nanotechnology researcher and editor-in-chief of Precision Nanomedicine. The theme of the second volume is about nano-enabled medical applications. The 19 articles collected here have already acquired more than 12,500 citations highlighting the importance and professional recognition of the work of these scientists in nanomedicine. The content includes the general overview of the field and a wide variety of applications that have been impossible without nanoscience and nanotechnology. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | OCLC-licensed vendor bibliographic record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanomedicine. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | MEDICAL / Biotechnology |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | SCIENCE / Biotechnology |
| Source of heading or term | bisacsh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Balogh, Lajos P., |
| Relator term | editor. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | Read Online |
| Uniform Resource Identifier | <a href="https://www.taylorfrancis.com/books/9780429399039">https://www.taylorfrancis.com/books/9780429399039</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | OCLC metadata license agreement |
| Uniform Resource Identifier | <a href="http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | eBook |
No items available.